An investigation of phosphopeptide binding to SH2 domain

Biochemical and Biophysical Research Communications

Volumn 306, Issue 1, 2003, Pages 225-230

  Lee, Jin Kak ^a   Moon, Taesung ^a   Chi, Myung Whan ^a   Song, Jin Soo ^a   Choi, Young Sang ^b   Yoon, Chang No ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

Author keywords

Alignment rule; Binding affinity; CoMFA; Phosphopeptides; QSAR; SH2

Indexed keywords

FUNCTIONAL GROUP; PHOSPHOPEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COMPUTER MODEL; CORRELATION ANALYSIS; ELECTRIC ACTIVITY; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY; RECEPTOR BINDING; SRC HOMOLOGY DOMAIN;

EID: 0038730721     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00932-X     Document Type: Article

References (21)

1. Hanks S.K., Quinn A.M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 241:1988;42-52.
2. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
3. Williams L.T. Signal transduction by the platelet-derived growth factor receptor. Science. 243:1989;1564-1570.
4. Koch C.A., Anderson D., Morgan M.F., Ellis C., Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science. 252:1991;668-674.
5. Cantley L.C., Auger K.R., Carpenter C., Duckworth B., Granziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell. 64:1991;281-302.
6. lck, reveals its oncogenic potential in fibroblasts. Proc. Natl. Acad. Sci. USA. 185:1988;4247-4251.
7. c-src: implications for regulation. Science. 231:1986;1431-1434.
8. c-src mutated in the carboxy-terminal regulatory domain. Cell. 49:1987;83-91.
9. lck. Nature. 362:1993;87-91.
10. Eck M.J., Atwell S.K., Shoelson S.E., Harrison S.C. Structure of the regulatory domains of the src-family tyrosine kinase Lck. Nature. 368:1994;764-769.
11. lck complexed with two phosphopeptides suggest a gated peptide binding site. J. Mol. Biol. 246:1995;344-355.
12. Narula S.S., Yuan R.W., Adams S.E., Green O.M., Green J., Philips T.B., Zydowsky L.D., Botfield M.C., Hatada M., Laird E.R., Zoller M.J., Karas J.L., Dalgarno D.C. Solution structure of C-terminal SH2 domain of the human tyrosine kinase syk complexed with a phosphotyrosine pentapeptide. Structure. 3:1995;1061-1073.
13. Pascal S.M., Singer A.U., Gish G., Yamazaki T., Shoelson S.E., Pawson T., Kay L.E., Forman-kay J.D. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ complexed with a high affinity binding peptide. Cell. 77:1994;461-472.
14. lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 and 1.8. Å resolution J. Mol. Biol. 256:1996;601-610.
15. Waksman G., Kominos D., Robertson S.C., Pant N., Baltimore D., Birge R.B., Cowburn D., Hanafusa H., Mayer B.J., Overduin M., Resh M.D., Rios C.B., Silverman L., Kuriyan J. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature. 358:1992;646-653.
16. Waksman G., Shoelson S.E., Pant N., Cowburn D., Kuriyan J. Binding of high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell. 72:1993;779-790.
17. Payne G., Stolz L.A., Pei D., Band H., Shoelson S.E., Walsh C.T. The phosphopeptide-binding specificity of Src family SH2 domains. Chem. Biol. 1:1991;99-105.
18. Piccione E., Case R.D., Domchek S.M., Hu P., Chaudhuri M., Backer J.M., Schlessinger J., Shoelson S.E. Phosphatidylinocitol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry. 32:1993;3197-3292.
19. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Birge R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., Cantley L.C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
20. Cramer III R.D., Patterson D.E., Bunce J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier protein. J. Am. Chem. Soc. 110:1988;5059-5067.
21. Sybyl Molecular Modeling Software, version 6.3. Sybyl theory manual. Tripos, Inc., St. Louis, 1996.